<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00534248</url>
  </required_header>
  <id_info>
    <org_study_id>V211-022</org_study_id>
    <secondary_id>2007_551</secondary_id>
    <nct_id>NCT00534248</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)</brief_title>
  <official_title>A Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity, Safety and Tolerability of Zostavax™ in Subjects 50-59 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      This study will look at how well Zostavax™ works in preventing shingles in participants ages
      50-59 years old.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Confirmed Herpes Zoster (HZ) Cases by Vaccination Group</measure>
    <time_frame>2 Years</time_frame>
    <description>Incidence rate of HZ cases was defined as the number of confirmed HZ cases per 1000 person-years of follow-up following vaccination. Vaccine efficacy for HZ was defined as the relative reduction in incidence rate of HZ in the group that received Zostavax™ compared with the group that received placebo based on the intent-to-treat population.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Varicella-zoster Virus (VZV) Antibody Response at 6 Weeks Post Vaccination by Vaccination Group</measure>
    <time_frame>6 Weeks</time_frame>
    <description>VZV antibody response as measured by Glycoprotein Enzyme-Linked Immunosorbent Assay (gpELISA) in the group that received Zostavax™ compared with the group that received placebo, based on the random subcohort population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting One or More Serious Adverse Experiences by Vaccination Group During the 42-day Postvaccination Follow-up Period</measure>
    <time_frame>Through 42 days post-vaccination</time_frame>
    <description>A serious adverse event is defined as any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing
hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22439</enrollment>
  <condition>Shingles</condition>
  <arm_group>
    <arm_group_label>Zostavax™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomized to receive Zoster Vaccine, Live (Zostavax™).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants randomized to receive Placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Zoster Vaccine, Live (Zostavax™)</intervention_name>
    <description>A single dose 0.65 ml Zostavax™ (Live, attenuated Zoster Vaccine) was administered by subcutaneous injection on Day 1.</description>
    <arm_group_label>Zostavax™</arm_group_label>
    <other_name>V211</other_name>
    <other_name>Zostavax™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Comparator: Placebo</intervention_name>
    <description>A single dose of 0.65 ml Placebo (A vaccine stabilizer of Zostavax™ with no live virus) was administered by subcutaneous injection on Day 1.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be between 50 - 59 years of age

          -  No fever on day of vaccination

          -  Females of reproductive potential must be willing to use acceptable form of birth
             control

        Exclusion Criteria:

          -  Have received chicken pox or shingles vaccine

          -  Have already had shingles

          -  Have recently had another vaccination

          -  Pregnant or breast feeding. Have participated in another research study in the last 30
             days

          -  You are taking certain antiviral drugs

          -  History of allergic reaction to any vaccine component, including gelatin or neomycin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>MedWatch - FDA maintained medical product safety Information</description>
  </link>
  <link>
    <url>http://www.merck.com/product/patients_caregivers/home.html</url>
    <description>Merck: Patient &amp; Caregiver U.S. Product Web Site</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2007</study_first_submitted>
  <study_first_submitted_qc>September 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2007</study_first_posted>
  <results_first_submitted>January 4, 2011</results_first_submitted>
  <results_first_submitted_qc>March 31, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 2, 2011</results_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Zostavax™</title>
          <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of Zoster Vaccine, Live (Zostavax™).</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of placebo.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11211"/>
                <participants group_id="P2" count="11228"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>VACCINATED</title>
              <participants_list>
                <participants group_id="P1" count="11186"/>
                <participants group_id="P2" count="11210"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10550"/>
                <participants group_id="P2" count="10555"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="661"/>
                <participants group_id="P2" count="673"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="353"/>
                <participants group_id="P2" count="375"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other protocol specified criteria</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="263"/>
                <participants group_id="P2" count="255"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Zostavax™</title>
          <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of Zoster Vaccine, Live (Zostavax™).</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of placebo.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11211"/>
            <count group_id="B2" value="11228"/>
            <count group_id="B3" value="22439"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.9" spread="2.8"/>
                    <measurement group_id="B2" value="54.8" spread="2.8"/>
                    <measurement group_id="B3" value="54.8" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6913"/>
                    <measurement group_id="B2" value="6972"/>
                    <measurement group_id="B3" value="13885"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4298"/>
                    <measurement group_id="B2" value="4256"/>
                    <measurement group_id="B3" value="8554"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Confirmed Herpes Zoster (HZ) Cases by Vaccination Group</title>
        <description>Incidence rate of HZ cases was defined as the number of confirmed HZ cases per 1000 person-years of follow-up following vaccination. Vaccine efficacy for HZ was defined as the relative reduction in incidence rate of HZ in the group that received Zostavax™ compared with the group that received placebo based on the intent-to-treat population.</description>
        <time_frame>2 Years</time_frame>
        <population>Intent-to-treat population defined as all participants randomized in the study according to the planned treatment, Zostavax or placebo, they were assigned.</population>
        <group_list>
          <group group_id="O1">
            <title>Zostavax™</title>
            <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of Zoster Vaccine, Live (Zostavax™).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of placebo.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Confirmed Herpes Zoster (HZ) Cases by Vaccination Group</title>
          <description>Incidence rate of HZ cases was defined as the number of confirmed HZ cases per 1000 person-years of follow-up following vaccination. Vaccine efficacy for HZ was defined as the relative reduction in incidence rate of HZ in the group that received Zostavax™ compared with the group that received placebo based on the intent-to-treat population.</description>
          <population>Intent-to-treat population defined as all participants randomized in the study according to the planned treatment, Zostavax or placebo, they were assigned.</population>
          <units>number of HZ cases/1000 person-years</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11211"/>
                <count group_id="O2" value="11228"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.994" lower_limit="1.346" upper_limit="2.847"/>
                    <measurement group_id="O2" value="6.596" lower_limit="5.361" upper_limit="8.030"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Vaccine efficacy with respect to HZ was defined as the relative reduction in incidence rate of HZ point estimate (95% CI) calculated as 1 minus the ratio of the estimated incidence rates of HZ in the zoster vaccine group and the placebo group.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <method>Conditional Exact Method</method>
            <param_type>point estimate</param_type>
            <param_value>.698</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.541</ci_lower_limit>
            <ci_upper_limit>.806</ci_upper_limit>
            <estimate_desc>The point estimate was for vaccine efficacy with respect to incidence of HZ.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Varicella-zoster Virus (VZV) Antibody Response at 6 Weeks Post Vaccination by Vaccination Group</title>
        <description>VZV antibody response as measured by Glycoprotein Enzyme-Linked Immunosorbent Assay (gpELISA) in the group that received Zostavax™ compared with the group that received placebo, based on the random subcohort population.</description>
        <time_frame>6 Weeks</time_frame>
        <population>Random subcohort population included 10% of all randomized participants randomly selected for immunogenicity assay, were vaccinated (according to actual treatment received), had results at prevaccination and at 6 weeks postvaccination. Results from participants with protocol violations that may impact the immunogenicity analysis were excluded.</population>
        <group_list>
          <group group_id="O1">
            <title>Zostavax™</title>
            <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of Zoster Vaccine, Live (Zostavax™).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of placebo.</description>
          </group>
        </group_list>
        <measure>
          <title>Varicella-zoster Virus (VZV) Antibody Response at 6 Weeks Post Vaccination by Vaccination Group</title>
          <description>VZV antibody response as measured by Glycoprotein Enzyme-Linked Immunosorbent Assay (gpELISA) in the group that received Zostavax™ compared with the group that received placebo, based on the random subcohort population.</description>
          <population>Random subcohort population included 10% of all randomized participants randomly selected for immunogenicity assay, were vaccinated (according to actual treatment received), had results at prevaccination and at 6 weeks postvaccination. Results from participants with protocol violations that may impact the immunogenicity analysis were excluded.</population>
          <units>gpELISA units/mL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1088"/>
                <count group_id="O2" value="1087"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="660.0" lower_limit="624.7" upper_limit="697.2"/>
                    <measurement group_id="O2" value="293.1" lower_limit="274.7" upper_limit="312.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <method>linear mixed longitudinal analysis model</method>
            <param_type>geometric mean titre ratio</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.2</ci_lower_limit>
            <ci_upper_limit>2.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting One or More Serious Adverse Experiences by Vaccination Group During the 42-day Postvaccination Follow-up Period</title>
        <description>A serious adverse event is defined as any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing
hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
        <time_frame>Through 42 days post-vaccination</time_frame>
        <population>All participants who were vaccinated according to actual treatment received (Zostavax or placebo) and had safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Zostavax™</title>
            <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of Zoster Vaccine, Live (Zostavax™).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of placebo.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting One or More Serious Adverse Experiences by Vaccination Group During the 42-day Postvaccination Follow-up Period</title>
          <description>A serious adverse event is defined as any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing
hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
          <population>All participants who were vaccinated according to actual treatment received (Zostavax or placebo) and had safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11094"/>
                <count group_id="O2" value="11116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit=".48" upper_limit=".79"/>
                    <measurement group_id="O2" value="61" lower_limit=".42" upper_limit=".70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis of proportion of participants reporting one or more serious adverse experiences reported within 42 days postvaccination.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Relative Risk</param_type>
            <param_value>1.133</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.805</ci_lower_limit>
            <ci_upper_limit>1.595</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious adverse events (SAEs) are presented that occurred from Day 1 to 182 postvaccination. Deaths that occurred any time during the study are also included. Non-serious AEs are presented for events that occurred from Day 1 to 42 postvaccination.</time_frame>
      <desc>AEs and SAEs were reported in participants who were vaccinated according to actual treatment received (Zostavax or placebo) and had safety follow-up.</desc>
      <group_list>
        <group group_id="E1">
          <title>Zostavax™</title>
          <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of Zoster Vaccine, Live (Zostavax™).</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Participants randomized to receive a single 0.65 ml subcutaneous injection of placebo.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="243" subjects_at_risk="11094"/>
                <counts group_id="E2" subjects_affected="233" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cardiomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Coronary artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypertrophic cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Mitral valve prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="11094"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital diaphragmatic hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Porphyria acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Thyroiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Oesophageal achalasia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pancreatic disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="11094"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hernia obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="11094"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Alcoholic liver disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Perforation bile duct</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="11094"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Bursitis infective staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Endocarditis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Epidemic nephropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Meningitis aseptic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pharyngeal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="11094"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Superinfection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Bladder injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Stent occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Synovial rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Ureteric injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Patellofemoral pain syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Anal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="11094"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of cervix uteri</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Borderline ovarian tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="11094"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Breast cancer stage II</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Endometrial cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Endometrial cancer stage III</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Fallopian tube cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Fibroadenoma of breast</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Nasal cavity cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Neurilemmoma benign</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Ovarian epithelial cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Throat cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Waldenstrom's macroglobulinaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cervical root pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Cubital tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Myasthenia gravis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Acute psychosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Drug dependence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Suicidal behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Laryngeal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="11094"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="11094"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7228" subjects_at_risk="11094"/>
                <counts group_id="E2" subjects_affected="2183" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" events="5409" subjects_affected="5351" subjects_at_risk="11094"/>
                <counts group_id="E2" events="484" subjects_affected="483" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" events="6276" subjects_affected="6005" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1052" subjects_affected="1025" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" events="1307" subjects_affected="1287" subjects_at_risk="11094"/>
                <counts group_id="E2" events="84" subjects_affected="78" subjects_at_risk="11116"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" events="4549" subjects_affected="4500" subjects_at_risk="11094"/>
                <counts group_id="E2" events="311" subjects_affected="309" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1509" subjects_affected="1041" subjects_at_risk="11094"/>
                <counts group_id="E2" events="1357" subjects_affected="917" subjects_at_risk="11116"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vice President of Late Stage Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp</organization>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

